Tangram Therapeutics
Biotechnology ResearchUnited Kingdom51-200 Employees
A specialist in computational drug discovery with a focus on developing RNA interference (“RNAi”) therapeutics
Innovative Therapeutic Focus Tangram Therapeutics specializes in computational drug discovery with a focus on RNA interference therapeutics, positioning it as a leader in cutting-edge biotech solutions that can benefit from advanced data management and analytic tools.
Strategic Collaboration Opportunities Recent partnerships with companies like Arcturis Data Limited and iTeos Therapeutics highlight opportunities for joint development projects and data integration services to accelerate drug discovery initiatives.
Funding and Growth Potential With $37 million in funding and a revenue range of 1 to 10 million dollars, there is significant scope for expanding technology infrastructure and sales efforts to support ongoing research and commercialization.
Market Engagement & Visibility Participation in prominent events such as the European Haemophilia Congress indicates an active approach to showcasing innovations, providing opportunities for targeted outreach and strategic partnerships.
Leadership & Talent Development The recent addition of senior executives like a new CFO and board members demonstrates a focus on strengthening leadership, which can facilitate enterprise growth and open avenues for executive-level collaborations.
Tangram Therapeutics uses 8 technology products and services including Font Awesome, GitLab, HSTS, and more. Explore Tangram Therapeutics's tech stack below.
| Tangram Therapeutics Email Formats | Percentage |
| First.Last@etherapeutics.co.uk | 95% |
| First-L@etherapeutics.co.uk | 3% |
| First@etherapeutics.co.uk | 1% |
| First.Middle@etherapeutics.co.uk | 1% |
Biotechnology ResearchUnited Kingdom51-200 Employees
A specialist in computational drug discovery with a focus on developing RNA interference (“RNAi”) therapeutics
Tangram Therapeutics has raised a total of $37M of funding over 5 rounds. Their latest funding round was raised on Jul 03, 2024 in the amount of $37M.
Tangram Therapeutics's revenue is estimated to be in the range of $1M$10M
Tangram Therapeutics has raised a total of $37M of funding over 5 rounds. Their latest funding round was raised on Jul 03, 2024 in the amount of $37M.
Tangram Therapeutics's revenue is estimated to be in the range of $1M$10M